Human beta-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection. - Wikidata - awgldk - TriplyDB

Human beta-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection.

Human beta-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection.

http://www.wikidata.org/entity/Q34124118

about

Through the looking glass, mechanistic insights from enantiomeric human defensins The Potential Use of Natural and Structural Analogues of Antimicrobial Peptides in the Fight against Neglected Tropical Diseases Advances in HIV microbicide development Antiviral mechanisms of human defensins Evaluation of Health Disparity in Bacterial Vaginosis and the Implications for HIV-1 Acquisition in African American Women Anti-HIV-1 activity of a new scorpion venom peptide derivative Kn2-7 Involvement of β-defensin 130 (DEFB130) in the macrophage microbicidal mechanisms for killing Plasmodium falciparum Virocidal activity of Egyptian scorpion venoms against hepatitis C virus.Mucosal transmission of human immunodeficiency virus Variation in human β-defensin genes: new insights from a multi-population study Human cervicovaginal mucus contains an activity that hinders HIV-1 movement.Cyclic and acyclic defensins inhibit human immunodeficiency virus type-1 replication by different mechanisms.Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies HIV type 1 fails to trigger innate immune factor synthesis in differentiated oral epithelium.CCR6 ligands inhibit HIV by inducing APOBEC3G.Perspectives for clinical use of engineered human host defense antimicrobial peptides HIV-Enhancing and HIV-Inhibiting Properties of Cationic Peptides and Proteins.Human Beta Defensin 2 Selectively Inhibits HIV-1 in Highly Permissive CCR6⁺CD4⁺ T Cells.Novel synthetic, salt-resistant analogs of human beta-defensins 1 and 3 endowed with enhanced antimicrobial activity.Increased levels of human beta-defensins mRNA in sexually HIV-1 exposed but uninfected individuals Modulation of HIV transmission by Neisseria gonorrhoeae: molecular and immunological aspects.Productive HIV-1 infection of human cervical tissue ex vivo is associated with the secretory phase of the menstrual cycle.Innate immunity against HIV: a priority target for HIV prevention research Critical issues in mucosal immunity for HIV-1 vaccine development.HIV is inactivated after transepithelial migration via adult oral epithelial cells but not fetal epithelial cells.Neisseria gonorrhoeae-induced human defensins 5 and 6 increase HIV infectivity: role in enhanced transmission.Effective control of Salmonella infections by employing combinations of recombinant antimicrobial human β-defensins hBD-1 and hBD-2 Female genital tract secretions and semen impact the development of microbicides for the prevention of HIV and other sexually transmitted infections.Immune responses to HIV in the female reproductive tract, immunologic parallels with the gastrointestinal tract, and research implications Selective transmission of R5 HIV-1 variants: where is the gatekeeper?Histatin 5-derived peptide with improved fungicidal properties enhances human immunodeficiency virus type 1 replication by promoting viral entry Genetic and Immunological Factors Involved in Natural Resistance to HIV-1 Infection.High transcript levels of vitamin D receptor are correlated with higher mRNA expression of human beta defensins and IL-10 in mucosa of HIV-1-exposed seronegative individuals.Innate immunity in the vagina (Part II): Anti-HIV activity and antiviral content of human vaginal secretions Barriers to mucosal transmission of immunodeficiency viruses.Heat-stable molecule derived from Streptococcus cristatus induces APOBEC3 expression and inhibits HIV-1 replication Vaginal innate immune mediators are modulated by a water extract of Houttuynia cordata Thunb Host factors influencing susceptibility to HIV infection and AIDS progression.Glances in Immunology of HIV and HCV Infection Factors Important to the Prioritization and Development of Successful Topical Microbicides for HIV-1

P2860

Q24652382-87D3E875-5242-4335-99A0-BC66C3800EA9 Q26797488-EF37F236-3544-4259-B320-2624536BE8B6 Q26852858-6B599EFB-E13D-487B-AF5D-CB7EF4C01B4B Q27023010-0F40A73A-B3F0-4176-BA42-67CA8F23F0B5 Q28068857-8551710F-996F-4181-A6D2-B1DF3851DF98 Q28482446-D46A6FDE-18B3-4536-8FCD-D08E2253AC5A Q30179429-2DAB938B-4479-4863-A254-A6EE8A9179C7 Q30389258-97072AE6-CA64-4C0A-9E53-8B2EF11328C0 Q30412036-F3FEDC2C-DEDE-4172-8B8B-D8DE96664BDA Q30540081-C7F3A8F4-E629-4CB4-956E-CE6BF1A3EF9C Q30542085-25C6925E-E36E-4A0B-936F-7168608F5F6E Q33543787-D4DD509F-14B6-411F-8EAD-E00655D156CF Q33627673-1CB8360C-0B99-4A44-8116-E138CEB556C1 Q33686842-8B96D9E5-0DE4-4CF6-ABB6-A9F9C49AF070 Q33697355-C4681566-6E10-4CEC-BE2F-2763214AFDC8 Q33700825-1A4C8C8E-9E17-472A-866D-C10BF3849364 Q33753950-C89B7DCC-5233-43EE-A43F-519ABB2DF23A Q33753961-2B128D72-81E5-40E1-9377-4EB00E219FBF Q33876601-FE1CB9DF-C008-446D-9196-CDFD6BC423EC Q34020111-EFF4211D-9343-404D-8FCA-D916F3EFB377 Q34108744-BE4C4102-1CA2-46BF-9207-A5147D4EB6F1 Q34127684-0B1352A2-CB17-47E1-8039-B1D843B44176 Q34243462-2C879B0F-D988-4CAB-8701-8AA7FDE380BB Q34459985-97760204-2B74-49D4-8B0F-E8874E37CA8A Q34554611-1013EE31-CB6B-49F1-9DE0-33DA2B2A7DF8 Q34589778-9A3528CE-2131-442E-AFB1-AAAC9AC03D18 Q34596799-BB3EFABB-CF06-471C-800C-F5C63D3CD299 Q34680240-DB917A1C-58FD-4041-934E-D2EF521FECEE Q34712244-4095902C-28C8-4421-94B8-6ACE3423E297 Q35018140-1BD28E7E-B902-48D8-BCF8-9B336844EB7A Q35024210-ADADE18E-1B04-4FD8-9DC2-813BA495FC15 Q35030053-D20ADB0E-0DAE-456C-A6CD-7CC64458B5EA Q35070462-9E67634F-E47E-478E-A0A6-E202616B6642 Q35078336-5F8EEC62-B679-41CD-B453-E5FD8E7661CD Q35140968-CA63BE25-2F37-425D-8D13-0DFF745043E0 Q35233493-0C1CF228-83FD-4ADF-9738-0A1C24004125 Q35664514-61BA684C-A6EF-48FE-95F0-36D797382F4F Q35995936-918AE073-B4DE-4D3E-BB61-875080171336 Q36032051-94373881-F78B-410D-89FA-4DE4C1A98C58 Q36111516-B99ECDAE-C536-40AB-9203-EB8CB62F866A

P2860

Human beta-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection.

http://www.wikidata.org/entity/Q34124118

description

2005 nî lūn-bûn

@nan

2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Human beta-defensins suppress ...... al role in mucosal protection.

@ast

Human beta-defensins suppress ...... al role in mucosal protection.

@en

Human beta-defensins suppress ...... al role in mucosal protection.

@nl

type

label

Human beta-defensins suppress ...... al role in mucosal protection.

@ast

Human beta-defensins suppress ...... al role in mucosal protection.

@en

Human beta-defensins suppress ...... al role in mucosal protection.

@nl

prefLabel

Human beta-defensins suppress ...... al role in mucosal protection.

@ast

Human beta-defensins suppress ...... al role in mucosal protection.

@en

Human beta-defensins suppress ...... al role in mucosal protection.

@nl

P1433

Q34124118-8D151811-B7FA-4DFB-B004-F6440307B2D7

P1476

Q34124118-677DF01D-CBBA-4E5E-B291-1B5CC9DC6067

P2093

Q34124118-0038DA8A-47C2-43F7-B599-5CD72995FE04

Q34124118-0FEFF84A-12BF-4BEF-BE18-D9374B6D9132

Q34124118-1595EF8C-1403-4620-A380-41797539CE7E

Q34124118-1C41787C-F3CE-4DFF-9767-5FFBA1C635A9

Q34124118-20C97ED3-779F-4453-B462-E52D92173E4F

Q34124118-36C2880A-7984-467D-AFAB-4F3FDC36231E

Q34124118-54006AAD-A754-4AC5-A1DB-1260A79B613D

Q34124118-826E4A63-B2F2-4C8F-8364-797DFC2EB6B2

Q34124118-86D3EFEE-6136-4A19-9D3E-4BDAC3595758

Q34124118-C6F38A7D-C46B-4DE0-9502-593E21B5A452

P2860

Q34124118-04D48350-3332-4FBB-8079-CFB1C17C0943

Q34124118-0D04C1EC-A07A-408B-B9A7-576BAEA4ADD4

Q34124118-0FDEBBA6-261C-4EBB-AD51-3FF1BF4AE417

Q34124118-103B2C80-11FE-4468-B578-351C600AF94F

Q34124118-148C1C86-F637-48ED-93E4-E4B496572146

Q34124118-1C9F00B2-6B50-484A-AD52-C6E2775163F5

Q34124118-1CFE04E5-5F01-4C80-96B7-DB48EF96153C

Q34124118-2665AE06-88A3-44C2-9CB9-534D25A57ACA

Q34124118-276BA9D9-20AA-4C63-A88B-255A9BC823B2

Q34124118-2A278741-3FFA-45E7-BCEB-6999F8283E02

P304

Q34124118-F82D4FD4-D5C7-413E-8086-AE0A85372681

P31

Q34124118-C45F56D5-B257-458F-80EE-59A085579B48

P356

Q34124118-AA7130AD-C96A-43FC-891F-B328A0A5DFE3

P407

Q34124118-2CC488E1-1C38-48FB-801F-8F9ECEF8FBCB

P433

Q34124118-5D75DDB6-AF3F-433B-AB13-F7BE62690381

P478

Q34124118-71DDD4D3-A592-4843-BA5D-09F29B2F911A

P50

Q34124118-C2B2F6F8-CE5B-4C17-803F-4C809B80DE76

P577

Q34124118-DC657F09-C40F-495C-A4FC-128C9DD610F5

P698

Q34124118-43CB212E-8F80-48AD-B821-ED45CFB02DFB

P932

Q34124118-B824C37E-428C-4300-8F60-B15BB3BAAAC4

P356

JVI.79.22.14318-14329.2005

P1433

Journal of Virology

P1476

Human beta-defensins suppress ...... ial role in mucosal protection

@en

P2093

Alfredo Garzino-Demo

http://www.w3.org/2001/XMLSchema#string

Carol Kleinman

http://www.w3.org/2001/XMLSchema#string

Catherine M Finnegan

http://www.w3.org/2001/XMLSchema#string

Gian M La Terra Maggiore

http://www.w3.org/2001/XMLSchema#string

Lingling Sun

http://www.w3.org/2001/XMLSchema#string

Paolo Garzino-Demo

http://www.w3.org/2001/XMLSchema#string

Robert Blumenthal

http://www.w3.org/2001/XMLSchema#string

Sid Berrone

http://www.w3.org/2001/XMLSchema#string

Tina Kish-Catalone

http://www.w3.org/2001/XMLSchema#string

Wuyuan Lu

http://www.w3.org/2001/XMLSchema#string

P2860

Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6

Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells

Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic

Purification and characterization of human neutrophil peptide 4, a novel member of the defensin family

Inhibition of HIV-1 infection by the beta-chemokine MDC

The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry

The CC chemokine I-309 inhibits CCR8-dependent infection by diverse HIV-1 strains

Discovery of five conserved beta -defensin gene clusters using a computational search strategy.

Primary structures of three human neutrophil defensins

Defensins. Natural peptide antibiotics of human neutrophils

P304

14318-14329

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.79.22.14318-14329.2005

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

79

http://www.w3.org/2001/XMLSchema#string

P50

Sayed F Abdelwahab

P577

2005-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16254366

http://www.w3.org/2001/XMLSchema#string

P932

1280242

http://www.w3.org/2001/XMLSchema#string